Omnicell (OMCL)
(Delayed Data from NSDQ)
$31.91 USD
+1.18 (3.84%)
Updated May 21, 2024 04:00 PM ET
After-Market: $31.90 -0.01 (-0.03%) 6:28 PM ET
3-Hold of 5 3
B Value D Growth A Momentum B VGM
Fundamental Charts
About PEG Ratio (TTM)
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
OMCL 31.91 +1.18(3.84%)
Will OMCL be a Portfolio Killer in May?
Zacks Investment Research is releasing its prediction for OMCL based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for OMCL
Omnicell (OMCL) Q1 Earnings Top Estimates, Revenues Down Y/Y
Omnicell (OMCL) Q1 Earnings and Revenues Top Estimates
OMCL: What are Zacks experts saying now?
Zacks Private Portfolio Services
GE HealthCare Technologies (GEHC) Meets Q1 Earnings Estimates
Here's Why You Should Retain Omnicell (OMCL) Stock Now
Omnicell (OMCL) Q4 Earnings Top Estimates, Gross Margin Down
Other News for OMCL
OMCL July 19th Options Begin Trading
Buy Rating on Omnicell Affirmed: Innovation and Growth Outlook Fuel Optimism for FY24 and Beyond
Piper Sandler Keeps Their Buy Rating on Omnicell (OMCL)
Omnicell Supports Global Charity Mercy Ships with Pharmacy Technology Donation
Analysts Conflicted on These Healthcare Names: PROCEPT BioRobotics (PRCT), Springworks Therapeutics (SWTX) and Omnicell (OMCL)